Piramal Pharma Limited had a revenue of 20.44B in the quarter ending Sep 30, 2025, with 5.69%. This bring the company's revenue in the last twelve months to 89.36B, Increased -2.17%. In the fiscal year ending Mar 31, 2025, Piramal Pharma Limited had annual revenue of 91.51B with 11.99% growth.